Hypertension-Related Renal Injury: A Major Contributor to End-Stage Renal Disease

American Journal of Kidney Diseases

Volumn 22, Issue 1, 1993, Pages 164-173

  Gordon Walker, W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aldosterone; angiotensin II; cholesterol; diabetes mellitus; end stage renal disease; Hypertension; prevention; reciprocal creatinine; renal function

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; BETA 2 MICROGLOBULIN; CREATININE; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; BETA 2 MICROGLOBULIN URINE LEVEL; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIURETIC THERAPY; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; NEGRO; PREVALENCE;

EID: 0027243925     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(12)70183-X     Document Type: Article

References (35)

1. The Medicare experience with end-stage renal disease: Trends in incidence, prevalence, and survival
2. Cases and observations, illustrative of renal disease accompanied with secretion of albuminous urine
3. Nephrosclerosis
4. Diuretic agents vs beta blockers: Comparison of effects on mortality of stroke, coronary events
5. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial: Racial and treatment effects
6. Renal insufficiency in treated essential hypertension
7. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus
8. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes
9. Relative contribution of type I and type II diabetics to the chronic dialysis population
10. Elevated BP and angiotensin II are associated with accelerated loss of renal function in diabetic nephropathy
11. Prospective study of the impact of hypertension upon kidney function in diabetes mellitus
12. Diuretics accelerate diabetic nephropathy in hypertensive insulin-dependent and non-insulin-dependent subjects
13. Hemodynamic theory of progressive renal disease: A 10-year update in brief review
14. Abnormally increased glomerular filtration rate in short-term insulin-treated diabetic subjects
15. Increased kidney size and glomerular filtration rate in early juvenile diabetes
16. The mechanism of acute deterioration of renal function in patients with renovascular hypertension following inhibition of angiotensin converting enzyme
17. Subpressor angiotensin infusion, renal sodium handling, and salt-induced hypertension in the dog
18. Central role of sodium in hypertension in diabetic subjects
19. Effect of angiotensin 11 blockade on dietary protein-induced renal growth
20. Multiple Risk Factor Intervention Trial: Risk factor changes and mortality results
21. Subgroup findings and comparisons with other trials
22. Five-year findings of the Hypertension Detection and Follow-up Program
23. Change in renal function during treatment in the Hypertension Detection and Follow-up Program (HDFP)
24. Lipoprotein(a) in diabetic patients with and without chronic renal failure
25. The relationships of diabetes, blood lipids, and uric acid levels in Polynesians
26. Major factors in the development of diabetes mellitus in 10,000 men
27. Prevention of phosphate-induced progression of uremic in rats by 3-phosphocitric acid
28. Calcium and phosphorus in chronic renal failure during nutritional therapy
29. Inhibition of PTH induced nephrocalcinosis by phosphocitrate
30. Evolving role of growth factors to acute and chronic disease
31. Renal injury from angiotensin II-mediated hypertension
32. Pharmacology of smooth muscle cell replication